abstract |
This invention is directed to 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds and also to a method for using such compounds in the treatment of androgen-dependent disorders. The compounds are prepared by the hydride reduction of an appropriate steroidal imine or enamine. |